cocaine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aungier, J; Cuesta, M; Morton, AJ; Ouk, K | 1 |
| Johnson, MA; Miller, CE; Rajan, V; Wightman, RM | 1 |
| Hondl, N; Ladurner, G; Staffen, W; Trinka, E; Zenzmaier, R | 1 |
| Bäckman, L; Farde, L; Ginovart, N; Halldin, C; Lundin, A; Pauli, S; Sedvall, G; Swahn, CG | 1 |
| Bäckman, L; Farde, L; Ginovart, N; Lundin, A; Robins-Wahlin, TB | 1 |
| Araujo, DM; Cherry, SR; Kornblum, HI; Tatsukawa, KJ; Toyokuni, T | 1 |
| Hickey, MA; Morton, AJ; Reynolds, GP | 1 |
| Gehlert, DR; Schoepp, DD | 1 |
| Brownell, AL; Brownell, GL; Davenport, PD; Elmaleh, DR; Hantraye, P; Isacson, O; Madras, BK; Maziere, M; Riche, D; Schumacher, JM | 1 |
9 other study(ies) available for cocaine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Chronic paroxetine treatment prevents disruption of methamphetamine-sensitive circadian oscillator in a transgenic mouse model of Huntington's disease.
Topics: Animals; Central Nervous System Stimulants; Circadian Clocks; Circadian Rhythm; Cocaine; Disease Models, Animal; Female; Huntington Disease; Male; Methamphetamine; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Motor Activity; Paroxetine; Receptors, Dopamine; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Vesicular Monoamine Transport Proteins | 2018 |
Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease.
Topics: Age Factors; Animals; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrochemistry; Huntingtin Protein; Huntington Disease; In Vitro Techniques; Methamphetamine; Mice; Mice, Transgenic; Microelectrodes; Motor Activity; Nerve Tissue Proteins; Nuclear Proteins; Time Factors | 2006 |
SPET investigations in extrapyramidal diseases using specific ligands.
Topics: Adult; Aged; Benzamides; Brain; Cocaine; Dopamine Antagonists; Hepatolenticular Degeneration; Humans; Huntington Disease; Iodine Radioisotopes; Male; Middle Aged; Movement Disorders; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Reference Values; Supranuclear Palsy, Progressive; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1997 |
PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
Topics: Adult; Benzazepines; Brain; Carbon Radioisotopes; Cocaine; Dopamine Antagonists; Female; Humans; Huntington Disease; Iodine Radioisotopes; Ligands; Magnetic Resonance Imaging; Male; Middle Aged; Neurons; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Presynaptic; Salicylamides; Tomography, Emission-Computed | 1997 |
Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes.
Topics: Benzazepines; Biomarkers; Brain; Carbon Radioisotopes; Carrier Proteins; Cocaine; Cognition Disorders; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Huntington Disease; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Memory; Middle Aged; Nerve Tissue Proteins; Organ Specificity; Perception; Predictive Value of Tests; Raclopride; Radiography; Receptors, Dopamine D1; Receptors, Dopamine D2; Reference Values; Salicylamides; Speech; Thinking; Tomography, Emission-Computed | 1997 |
Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
Topics: Animals; Autoradiography; Benzazepines; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Energy Metabolism; Female; Fluorodeoxyglucose F18; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Huntington Disease; In Situ Hybridization; Nerve Degeneration; Neurotoxins; Quinolinic Acid; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Spiperone; Substantia Nigra; Tomography, Emission-Computed; Tritium | 2000 |
The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease.
Topics: Aging; Animals; Behavior, Animal; Brain; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Disease Progression; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Glucose Tolerance Test; Huntington Disease; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Spatial Behavior; Survival Rate | 2002 |
Striatal quinolinic acid lesions increase [3H]WIN 35,428 binding to the dopamine transporter.
Topics: Animals; Autoradiography; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Huntington Disease; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Quinolinic Acid; Rats; Rats, Sprague-Dawley | 1992 |
A primate model of Huntington's disease: functional neural transplantation and CT-guided stereotactic procedures.
Topics: Animals; Apomorphine; Brain Tissue Transplantation; Carbon Radioisotopes; Caudate Nucleus; Cocaine; Deoxyglucose; Female; Fetal Tissue Transplantation; Fluorodeoxyglucose F18; Glucose; Graft Survival; Huntington Disease; Ibotenic Acid; Male; Motor Activity; Neurotoxins; Papio; Putamen; Quinolinic Acid; Rats; Stereotaxic Techniques; Tomography, Emission-Computed; Tomography, X-Ray Computed; Transplantation, Heterologous | 1992 |